Find Furazidin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Furazidin, 1672-88-4, Furazidine, Akritoin, Furaginum, 1-((3-(5-nitro-2-furyl)allylidene)amino)hydantoin
Molecular Formula
C10H8N4O5
Molecular Weight
264.19  g/mol
InChI Key
DECBQELQORZLLP-UAIOPKHMSA-N
FDA UNII
K2R4N34Y9I

Furazidin
Nitrofuran derivative anti-infective agent used for urinary tract infections.
1 2D Structure

Furazidin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[(E)-[(E)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]imidazolidine-2,4-dione
2.1.2 InChI
InChI=1S/C10H8N4O5/c15-8-6-13(10(16)12-8)11-5-1-2-7-3-4-9(19-7)14(17)18/h1-5H,6H2,(H,12,15,16)/b2-1+,11-5+
2.1.3 InChI Key
DECBQELQORZLLP-UAIOPKHMSA-N
2.1.4 Canonical SMILES
C1C(=O)NC(=O)N1N=CC=CC2=CC=C(O2)[N+](=O)[O-]
2.1.5 Isomeric SMILES
C1C(=O)NC(=O)N1/N=C/C=C/C2=CC=C(O2)[N+](=O)[O-]
2.2 Other Identifiers
2.2.1 UNII
K2R4N34Y9I
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Furazidin

2. Solafur

2.3.2 Depositor-Supplied Synonyms

1. Furazidin

2. 1672-88-4

3. Furazidine

4. Akritoin

5. Furaginum

6. 1-((3-(5-nitro-2-furyl)allylidene)amino)hydantoin

7. 1-[(e)-[(e)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]imidazolidine-2,4-dione

8. K2r4n34y9i

9. Nf 416

10. F-35

11. 1-((3-(5-nitro-2-furyl)allylidene)amino)-hydantoin

12. 1-[(e)-[(z)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]imidazolidine-2,4-dione

13. Furamag

14. 1-((3-(5-nitrofuran-2-yl)allylidene)-amino)imidazolidine-2,4-dione

15. 1-(((1e,2e)-3-(5-nitrofuran-2-yl)allylidene)amino)imidazolidine-2,4-dione

16. 1-{[(1e,2e)-3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-2,4-dione

17. Ccris 1199

18. 1-(3-(5-nitro-2-furyl)-n-2-propenylidine)amino-hydantoin

19. Brn 0307076

20. Unii-k2r4n34y9i

21. Furagin (tn)

22. Furazidin [mart.]

23. Furazidin [who-dd]

24. 1-[3-(5-nitro-2-furyl)allylidenamino]hydantoin

25. 4-24-00-01048 (beilstein Handbook Reference)

26. Schembl3194895

27. Chembl3707254

28. Hydantoin, 1-((3-(5-nitro-2-furyl)allylidene)amino)-

29. Schembl17292896

30. J01xe03

31. Dtxsid101030908

32. Ex-a1974

33. Bdbm50549808

34. S3709

35. Stk368597

36. Zinc31430194

37. 1-((3-(5-nitro-2-furanyl)-2-propenylidene)amino)-4-imidazolidinedione

38. 2,4-imidazolidinedione, 1-((3-(5-nitro-2-furanyl)-2-propenylidene)amino)-

39. Akos005444359

40. Ccg-267084

41. Cs-0798

42. Db13475

43. Bs-49182

44. Hy-77036

45. D07998

46. 672f884

47. A810846

48. 1-(3-(5-nitro-2-furyl)-n-2-propenylidine)aminohydantoin

49. 1-(((e)-3-(5-nitrofuran-2-yl)prop-2-enylidene)amino)imidazolidine-2,4-dione

50. 2,4-imidazolidinedione, 1-[[3-(5-nitro-2-furanyl)-2-propen-1-ylidene]amino]-

2.4 Create Date
2006-07-03
3 Chemical and Physical Properties
Molecular Weight 264.19 g/mol
Molecular Formula C10H8N4O5
XLogP30.5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass264.04946937 g/mol
Monoisotopic Mass264.04946937 g/mol
Topological Polar Surface Area121 Ų
Heavy Atom Count19
Formal Charge0
Complexity455
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count2
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Infective Agents, Urinary

Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)


4.2 ATC Code

J - Antiinfectives for systemic use

J01 - Antibacterials for systemic use

J01X - Other antibacterials

J01XE - Nitrofuran derivatives

J01XE03 - Furazidin


API SUPPLIERS

read-more
read-more

01

Olpha

Latvia

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SupplySide West 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOlpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.

Flag Latvia
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF ASMF arrow-down AUDIT
Olpha

02

Menadiona

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SupplySide West 2024
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

In partnership Olainfarm will manage Furagins (Furaginum) regulatory affairs, distribution and promotion in Latvia, Russia, Kazakhstan, Belarus, Ukraine, and other countries and Adalvo will be responsible for development, manufacturing and will support market activities.


Lead Product(s): Furazidin

Therapeutic Area: Infections and Infectious Diseases Brand Name: Furagins

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement June 16, 2021

Olpha

01

Olpha

Latvia
arrow
SupplySide West 2024
Not Confirmed

Lead Product(s) : Furazidin

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Approved

Partner/Sponsor/Collaborator : Not Applicable

Deal Size : Undisclosed

Deal Type : Agreement

Details : In partnership Olainfarm will manage Furagins (Furaginum) regulatory affairs, distribution and promotion in Latvia, Russia, Kazakhstan, Belarus, Ukraine, and other countries and Adalvo will be responsible for development, manufacturing and will support m...

Brand Name : Furagins

Molecule Type : Small molecule

Upfront Cash : Undisclosed

June 16, 2021

Olpha
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

read-more
read-more

01

Olpha

Latvia
arrow
SupplySide West 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOlpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.

Flag Latvia
Digital Content Digital Content

Regulatory Info :

Registration Country : Latvia

Furaginum

Brand Name : Furasol

Dosage Form : Powder for Preparation...

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Latvia

Olpha

01

Olpha

Latvia
arrow
SupplySide West 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOlpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.

Flag Latvia
Digital Content Digital Content

Packaging :

Regulatory Info :

Furaginum

Dosage : Powder for Preparation...

Dosage Strength : 100MG

Brand Name : Furasol

Approval Date :

Application Number :

Registration Country : Latvia

Olpha

02

Olpha

Latvia
arrow
SupplySide West 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOlpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.

Flag Latvia
Digital Content Digital Content

Regulatory Info :

Registration Country : Latvia

Furaginum

Brand Name : Furagin

Dosage Form : Tablet

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Latvia

Olpha

02

Olpha

Latvia
arrow
SupplySide West 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOlpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.

Flag Latvia
Digital Content Digital Content

Packaging :

Regulatory Info :

Furaginum

Dosage : Tablet

Dosage Strength : 50MG

Brand Name : Furagin

Approval Date :

Application Number :

Registration Country : Latvia

Olpha

03

Hasco-Lek

Poland
SupplySide West 2024
Not Confirmed
arrow

Hasco-Lek

Poland
arrow
SupplySide West 2024
Not Confirmed

Furazidin

Brand Name : Furaginum Hasco

Dosage Form : Tablets

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Poland

blank

03

Hasco-Lek

Poland
SupplySide West 2024
Not Confirmed
arrow

Hasco-Lek

Poland
arrow
SupplySide West 2024
Not Confirmed

Furazidin

Dosage : Tablets

Dosage Strength : 50MG

Brand Name : Furaginum Hasco

Approval Date :

Application Number :

Registration Country : Poland

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty